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One of the prime fundamentals of biology is the transcription of deoxyribonucleic acid 
(DNA) into ribonucleic acid (RNA) and translation of RNA into proteins [1]. To regulate 
various cellular activities, proteins then undergo post-translational modification. Post-
translational modification is a chemical modification of the proteins usually caused by 
covalent bonding with   molecules containing phosphate, methyl, acetyl, lipids or 
carbohydrates. The addition of a phosphate group to a protein is commonly defined as 
protein phosphorylation. It is catalysed by kinases, which transfer a phosphate group from 
a phosphate donor to the protein [2]. This modifies the biological activity of the proteins 
by generating protein dependent functional cell aberrations [3]. It is the proteins with 
serine, threonine, tyrosine or histidine amino acid residues that undergo this post-
translational modification, which brings conformational changes in its structure [4]. 
Phosphorylation of proteins is a reverse chemical reaction and the opposite of it is called 
protein dephosphorylation, which is the removal of phosphate from the protein and is 
catalysed by the enzymes called protein phosphatases [5].  
Phosphate groups play an important part in the various cell mechanisms, acting as 
building blocks for DNA and RNA. Phosphates are also significant components of the 
energy generating molecules (e.g. ATP) in all metabolic processes [6]. The role of 
phosphorylation is significant in the regulation of many processes such as mitosis and 
carbohydrate metabolism [3] and acts as a switch that turns on and off various cellular 
mechanisms. Its impact on cellular processes depends on how different proteins behave 
in their phosphorylated and dephosphorylated states. Phosphorylation was originally 
discovered by Carl and Getry Cori in late 1930s as a control mechanism while studying 
glycogenolysis [1]. However, Fisher and Kerb understood the true nature of 
glycogenolysis many years later while working on the enzyme phosphorylase kinase, 
which led to authentic discovery of the protein phosphorylation mechanism. This is 
because glycogenolysis involved several secondary messengers and other factors, which 
were discovered between that period. Finally, protein kinase activity was understood 
when Gene Kennedy in 1954 and Earl Sutherland discovered the secondary messengers 
which trigger phosphorylation in response to certain cellular stimuli. For instance when 
the body is in need of energy, phosphorylase kinase becomes phosphorylated switching 
from its inactive-b to active-a form, which converts the stored glycogen into glucose [7].  
 
Role of Protein Phosphorylation  
In this section the role of protein phosphorylation in cellular metabolism is explained with 
two different examples before explaining how it can then lead to disease. One essential 
metabolic process which is regulated specifically by protein phosphorylation is 
glycogenolysis, i.e. conversion of glucose into energy [7]. In this process, when blood 
sugar levels are low, the glucagon hormone is released into the blood and binds to the 
surface of liver cells. This activates the (cyclic adenosine monophosphate (cAMP) that 
binds to the regulatory receptors of glycogen phosphorylase kinase, turning it on, leading 
it to become phosphorylated. This phosphorylated state of glycogen phosphorylase kinase 
leads to phosphorylation of glycogen phosphorylase and activates it to convert glycogen 
into glucose. The resultant energy is then used by the cells to perform various 
physiological processes.  
There are over 500 protein kinases and about 30% of the human proteins undergo 
phosphorylation to perform essential cellular activities [8]. Therefore, it is not surprising 
that abnormal phosphorylation should turn out to be a cause of human disease [9].  There 
are over 400 diseases that are linked with the phosphorylation of proteins, with mostof 
the diseases caused by mutations in the genes that regulate kinases that alter the 
phosphorylation sites in a protein.  For instance in Alzheimer disease, Tau proteins are 
the major constituents of intraneuronal and glial fibrillar lesions and are referred to as 
‘tauopathies’[10], [11]. Molecular analysis has revealed that an abnormal 
phosphorylation is one of the important events in the process leading to the disorder. 
Similarly, mutations in somatic cells has been reported to encourage phosphorylation of 
proteins which induces malignancy in the cells [12]. Figure 1 shows a schematic where 
phosphorylation of proteins activates the cells and makes it cancerous. It also depicts how 
an inhibitor can stop the cell from being cancerous.   
 Figure Error! No text of specified style in document.  schematic of protein phosphorylation A) damage 
to the cell upon phosphorylation of proteins B)No phosphorylation in the presence of inhibitor 
Kinase inhibitors 
Kinases inhibitors are the most funded target in the drug discovery market [13]. Kinase 
inhibitors are a special kind of enzyme inhibitors that slows or impedes the activity of the 
enzymes called kinases. The most important use of kinase inhibitors is in cancer cure 
therapy [14]. In this therapy, the patient is injected with a specific kinase inhibitor as a 
form of chemotherapy.   The kinase inhibitors are given as a single therapy or as a 
combinatorial cancer treatment with radiation therapy [15].  Kinase inhibitors usually 
work by binding covalently or non-covalently to the kinases [16].   Inhibitors that bind 
covalently block kinase activity by binding to the Cysteine (Cys) residue either on the 
ATP active site or around the active site.   For instance in epidermal growth factor 
receptor (EGFR) kinase the Cys residue is on the ATP active site and the extracellular 
signal-regulated kinase 2 (ERK2) kinase Cys residue is on the d… f… g… -motif (DFG-
motif) around the active site. DFG-motif is a combination of three amino acids aspartic 
acid- phenylalanineglycine (Asp-Phe-Gly) [17].  Non-covalently binding inhibitors bind 
to the hinge region of the kinase. These can further be classified into ATP-competitive or 
non-ATP-competitive inhibitors. Competitive inhibitors compete with the high 
concentrations of intracellular ATP to attach on the kinase. The non-ATP-competitive 
inhibitors act by inducing a conformational shift in the kinase such that it is no longer 
able to function [18].   
Characteristics of protein-phosphorylation reaction 
The protein phosphorylation reaction involves the release of a proton (H+) and the transfer 
of a phosphate group from a donor (e.g. ATP), facilitated by kinase, resulting in a strong 
negative charge. Measuring the change in the charge of the protein after phosphorylation 
is one method of identifying protein phosphorylation. Another method could be to detect 
the release of protons.  ATP consists of three phosphoryl groups with the terminal 
phosphoryl (called as gamma (γ) phosphoryl) group being the one that is transferred to 
the proteins upon phosphorylation (figure 2) [17], [19].  Therefore, a modification at the 
γ-phosphoryl group that generates either optical or electrical response can be 
incorporated. For instance, modifying γ-phosphoryl with a sulphide bond can allow 
attachment of gold nanoparticles (AuNPs) after transfer to the proteins. Presence of 
AuNPs can then be analysed using biosensing techniques such as localized surface 
plasmon resonance technique. 
 Figure 2: Scheme showing phosphorylation reaction 
Methods that have been reported to assess kinase activity include colorimetric, 
fluorescence, optical, electrochemical, radioactive and spectroscopic techniques.  The 
detection mechanism of most of these usually involves either phospho-specific 
recognition of proteins or quantifying the phosphorylation product.  Recent 
developments have encouraged the use of nano-scale materials, for example gold and 
silver nanostructures, quantum dots, graphene oxide, carbon nanotubes, magnetic beads 
and semiconductor materials to analyse kinase activity.  The implementation of these 
nano hunks has greatly improved the detection limits and selectivity of protein 
phosphorylation reaction. Yet, there are bottlenecks that have hindered the potential of 
these advancements to transform into high throughput drug screening tools.  
The following sections will aim to present the biography of kinase drug discovery tools 
developed in academia and industry. In brief it will contextualize the need to develop 
technologies for protein phosphorylation analysis by presenting progresses from past to 
present in the kinase biosensor development.  
Conventional Biochemical assay 
Conventional biochemical assay uses a label, for instance an antibody, to detect the 
analyte of interest. Based on the label, analysis tools that are employed to detect the 
phosphorylation of proteins can be categorised into phospho-specific antibody and 
radioactive-labelled techniques. These assays are carried out using western blots or on a 
microtitier plate based ELISA platforms.  
Western blot 
In pharmaceutical research western blot is a standard method used to assess the post 
translational modification of proteins. This is because the technique does not require 
expensive laboratories equipment necessary to perform the experiments and the assay 
steps are user friendly to carry out.  The first step of the assay involves passing the 
sample through a polyacrylamide gel. The process consists of using sodium dodecyl 
sulfate (SDS) to impart negative charge on the proteins that assists size dependent 
movement of proteins through the sample. This whole process of separating protein 
samples according to their size is called as Polyacrylamide gel electrophoresis (PAGE). 
Next step involves transfer of the sample from the gel to a membrane usually made of 
polyvinylidene fluoride (PVDF) or nitrocellulose. From the membrane the analyte of 
interest is detected using antibodies that produces a chemo-luminescent signal to detect 
the analyte of interest. Detection of phosphorylated protein and screening of inhibitors of 
kinase has been demonstrated using this method by in several studies [5]–[13]. While 
antibody based western blot eliminates the use and waste disposal requirements of 
radioisotopes, it is a very laborious technique and is not suitable for high throughput 
screening of inhibitors. The usual time for the assay varies from 24 to 72 hours so it may 
take a week to screen for instance 3-5 inhibitors. In addition, this technique provides 
limited information on the kinetics of the reaction therefore it is only suitable as a 
validating tool to observe the presence of phosphorylated proteins in an unknown solution 
[14].    
Enzyme-linked immuno sorbent assay (ELISA) 
ELISA is another conventional method in pharmaceutical research that is frequently used 
for measuring protein phosphorylation [15]–[19]. ELISA is usually carried out in a high 
throughput reaction platform (96 well plate). These ELISA plate are either made up of 
glass or polystyrene that facilitates immobilisation of enzymes and proteins easily. The 
technique is more quantitative than western blot because the calibration of the detection 
mechanisms is standardised. This means that the interpretation of the change in the signal 
is quantifiable by utilizing a calibrated standard [20]. The detection mechanisms usually 
involve colorimetric or fluorometric detections [21]–[30]. The analyte of interested for 
instance the phosphorylated proteins are captured by antibodies that are generally tagged 
with enzyme which generate fluorescence or colour change signal. There are some 
loopholes of ELISA that has temporised the use of ELISA plates as trademark drug 
screening device. One of them is that it doesn’t allow detection of the analyte in real time 
and therefore obtaining information of kinetics and binding specificities of the inhibitor 
is limited.  In addition, the coloured or fluorescent product is prone to quenching effects 
that may cause the system to give false signals. Lastly, since it involves labelling the 
phosphorylation event, there is always a possibility of non-specific attachment of the 
labels that again may provide unreliable signals.  
Radioactive labelled assays 
The γ-phosphoryl group of ATP, which is transferred to the protein upon phosphorylation, 
is modified with radioactive isotope 32P, 33P or radioactive orthophosphates [31]. The 
phosphorylated proteins are then detected using autoradiography. Autoradiography is a 
technique of measuring the distribution of radioactivity on a surface.  The amount of 
radioactivity is qualitatively proportional to the amount of phosphorylation.  Although 
radioactive assays are quite sensitive in detecting the amount of phosphorylation in a 
given sample however it has a major disadvantage of not being environmental friendly.  
Radioactive isotope can damage the cells of the human body and can induce carcinogenic 
mutations. Therefore carrying out a radioactive assay may cause life-threatening 
complications.  Since radioisotopes has also the potential to damages the proteins, there 
is a high probability that inhibitor of kinase under test loose its function. Hence, 
radioactive assays for screening inhibitors of kinases are discouraged to use.   
Mass spectroscopy 
The addition of phosphate group adds a negative charge to the protein in addition to the 
increase in its mass. Therefore, it is not surprising that mass spectroscopy (MS) has been 
regarded as a comprehensive tool in the detection of phosphorylated proteins. In this 
technique the sample to be analysed is ionized to cations, which are separated according 
to their mass and charge in a magnetic field. The separated ions are then detected to 
produce a record of ions as a function of mass/charge. Although MS is a very sensitive 
technique with high resolution in identifying a single proton, it is not efficient in 
distinguishing a non-phosphorylated protein from a phosphorylated one. This is mainly 
attributed to the trade off with the MS principle that comes in when there is a mass and 
charge change in protein upon phosphorylation. There is poor ionization of phospho-
proteins since they are negatively charged and the ion source that ionises them in positive 
mode makes them loose their negative charge. This generates a very weak signal from 
phosphopeptides especially in the presence of high abundance of non-phosphorylated 
proteins. Secondly, stoichiometric levels of phosphoprotein may be very low and 
phosphopeptides have relatively low ion abundance in the presence of non-
phosphorylated peptides. Lastly, improper sample preparation or peptide fragmentation 
may cause phosphate groups on phosphoserine and phosphothreonine to decompose. To 
overcome these drawbacks, several strategies have been proposed to analyse phospho 
proteins with MS techniques. This includes antibody enrichment, chemical modification 
and affinity tag based chromatography methods [32]. 
Quartz crystal microbalance 
Quartz crystal microbalance (QCM) is a sensor that measures mass per unit area as a 
change in the frequency of an oscillating quartz crystal. The addition of mass upon 
addition of phosphate group or attachment of functional kinase to its substrate in the 
presence/absence of a kinase inhibitor can be monitored by QCM to develop drug 
screening devices. Xu et al. [33], [34] described one-step detection strategy for kinases 
using QCM. An aptameric peptide (IP20) was used to attach PKA kinase via RRNAI motif 
of the kinase. A change of over -250 Hz was observed on the QCM upon attachment of 
kinase. These changes were observed in the real time and the reaction was completed in 
4 minutes. QCM has also been used to distinguish phosphorylated protein from the 
dephosphorylated ones [35]. In this work authors monitor the attachment of 3 biotinylated 
phospho-tags on the phosphorylation/dephohsphorylated proteins using QCM. The 
attachment of their most sensitive phosphor-tag (monobiotinylated) at a concentration of 
0.1 µg/ml revealed a change of around -40 Hz. Other phosphorylation studies using QCM 
are that of DNA phosphorylation by polynucleotide kinase [36] and the phosphorylation 
of polycystin-2  to obtain the binding affinities and kinetic constants of the reaction [37]. 
The advantages of using QCM for kinase assays is that  the real time monitoring of the 
reaction can be achieved in addition to the detection of mass binding events. This may 
provide useful information of the kinase inhibitor under screening trials. For instance, the 
kinetics of an inhibitor can provide information on how fast the drug would work or 
information on its non-specificity could be extracted. However, there are few loopholes 
in the QCM detection that make researchers a cautious while using QCM.  
 
Figure 3 Xu el al. approach to detect kinase using Aptameric sensor on QCM  produced from [34] with 
permission from publisher   
The main disadvantages are the over estimation of the mass binding events and an 
approximate detection limit of 1 ng/cm2. Another loophole is that it is difficult to use 
quartz crystal as a multiple channel platform. In addition, since most of the measurements 
done on QCM are preferable in a liquid flow, there is a requirement of a steady flow over 
the sensor surface with at least 50 µl of buffer required [38]. These complexities have 
limited the use of QCM as an independent validating tool and often a conformation tool 
is required to support the inferences from QCM. 
Nanoparticle based technologies 
Nanoparticles have been widely used in biosensing applications either to detect the 
presence an analyte or enhance the detection signal. For the analysis of kinase assay or 
the detection of phosphorylated proteins, the use of  magnetic particles and the gold 
nanoparticles (AuNPs) with optical properties has been reported by several research 
groups [39]. Recently Su at el. induced crosslinking in AuNPs using phosphorylated 
proteins and quantified it via colorimetric assay [40]. They exploited the negative charge 
imparted on the proteins upon phosphorylation to aggregate the AuNPs. AuNPs are 
usually redish pink in colour (the colour becomes lighter when the size of the nanoparticle 
is increase) and upon aggregation the colour turns blue. Different shades of blue colour 
can be obtained with different amounts of aggregation. The authors claim that different 
amounts of phosphorylation generates varied amounts of aggregation. In this way naked 
eye distinction of phosphorylated proteins from the dephosphorylated can be achieved 
[41]. Other approaches using AuNPs have also been used to enhance the electrochemical 
signals from  the phosphorylated proteins [42]  and employed to either enable optical 
detection like LSPR [43] or enhance SPR signal [44] [45].  
 Figure 4 Kinase assay using AuNPs produced from [41] with permission from publisher 
Metal oxide nanoparticles have been reported to have specificity for phosphoryl-group 
and has therefore been used to detect phosphorylation [46], [47]. Chen et al. carried out 
separation of phosphorylated α and β-caseins in a mixed in non-fat milk and egg white in 
the presence/absence of  phosphatase inhibitor using alumina coated magnetic 
particles[48].  The phosphatase inhibitor avoids the removal of phosphate group from 
the proteins and allows the phosphorylated protein to attach on the alumina coated 
magnetic nanoparticles.  The magnetic particles were then extracted using magnet and 
analysed using mass spectroscopy to confirm the attachment of phosphoprotein on them.  
Similarly Wang et al. recently purified phosphorylated  peptides using zirconium oxide 
coated iron-oxide magnetic particles [49].  An approach where phosphorylated peptides 
were extracted from a solution using zirconium magnetic particles and analysed using a 
portable glucose sensor was also recently demonstrated by Yang at el. [50].  
 Figure 5 Separation of phosphoproteins using magnetic particles[48]; produced with permission from the 
publisher 
While the detection methodologies using nanoparticles have an advantage of making the 
system smaller and simple to use, it might have low impact for screening inhibitors of 
kinase. One reason for this is that inhibitors containing phosphoryl group that have non-
specific attachment on the nanoparticles may give a false signal.  Secondly it is not easy 
to produce homogenous nanoparticles of same shape and size therefore the signal may 
vary from sample to sample. In addition it is not a trivial task to detect real time changes 
from nanoparticle based detection system. For instance, complex phenomenon like 
plasmonic coupling or magneto plasmonic coupling occurs when AuNPs or magnetic 
particles are coupled on real time detection systems like SPR and QCM. This makes the 
detection of the analytical more qualitative than quantitative.   
Electrochemical Biosensors 
Electrochemical detection involves commingling of electronics and reaction chemistry. 
The principle is based on the measurement of change in the surface charge of the electrode 
due to the activity of analyte in contact with electrode. This change in charge as a function 
of time is amplified and recorded as current. When a protein gets phosphorylated, it 
becomes negatively charged and therefore this change in charge makes the 
electrochemical detection feasible. Electrochemical methods involving potentiometry 
and amperometry are some of the techniques used to detect protein phosphorylation [51]–
[55]. In potentiometry systems the measure of potential difference at zero current detects 
the analyte. Most commonly used potentiometric biosensor is an ion-sensitive field effect 
transistor (ISFET) or an open circuit potential (OCP) biosensor.  
Formisano et al. reported a multimode electrochemical biosensor where OCP was used 
to detect phosphorylation of proteins in the absence and presence of kinase inhibitor [56]. 
A real time detection of the kinase that gives an insight of enzymatic kinetics was 
achieved using this system.  In the same work amperometric detection of kinase was 
achieved using differential pulse voltammetry (DPV). Voltamentry is a type of 
amperometric technique where the analyte gets oxidized or reduced by the application of 
a varying voltage between reference and working electrode. The measure of the analyte 
is given by measuring the changes in the current. In another work Song et al. used 
adenosine-59-[γ -ferrocene] triphosphate to carry out phosphorylation of proteins, figure 
6. In their approach phosphorylated proteins had the presence of ferrocene that was 
detected using cyclic voltammetry. The corresponding current was the measure of 
phosphorylation activity [52][57].  
  
 
Figure 6 Detection of phosphorylation using cyclic voltammetry: Curve (a) phosphorylation (b) control; 
[52] produced with permission from publisher 
 The interface of electrochemistry with nanoparticles has made the electrochemical 
detection techniques more sensitive and robust. [58]. For instance, Kerman et al. 
demonstrated the application of AuNPs in the detection of protein phosphorylation 
[51][53]. They immobilized the kinase substrate on screen-printed electrodes and coupled 
the phosphorylation reaction with biotinylation of it. The biotinylated-phosphorylated 
kinase binds to the Au nanoparticles coated with streptavidin. In another report they 
measured differential pulse voltammetry response of AuNPs to monitor the activity of 
kinase and its substrate [53]. In addition, Li et al. proposed a strategy based on HRP 
linked catalysis where AuNPs were used for the signal amplification [55]. Impedemetric 
tools like impedance spectroscopy, voltage–current and charge-transfer characteristics 
have also been reported to be useful in determination of protein phosphorylation events. 
For instance, change in charge of self-assembled monolayer of peptides upon 
phosphorylation was also seen by Cao et al. Another example with label-free 
phosphorylation detection was demonstrated by Yitzchaik et al. [54]. They immobilized 
substrate and kinase in monolayers and saw a decrease in the electrochemical impedance 
of gold electrodes and a negative shift in gate voltage of field effect transistor upon 
phosphorylation [54].  
One of the great advantages of using electrochemical techniques for the phosphorylation 
detection is its high sensitivity. Secondly the electrodes are simple to use, time saving and 
large amount of data can be acquired within short duration. In addition, electrochemical 
detection techniques have the capacity of monitoring binding events that happen during 
a chemical reactions.  However, achieving high throughput using these techniques is 
extremely challenging that limits its use in drug discovery applications.  
MEMS based tools 
Micro electro mechanical systems (MEMS) based cantilevers have been very useful in 
performing label-free biochemical assays. The cantilevers work on the principle of 
converting mechanical deformation into an electrical signal upon addition of mass. These 
structures are usually comprised of a transducing element in the form of a capacitive, 
piezoelectric or piezoresistive actuator integrated to respond to the changes in mechanical 
structures. Eun Yang’s group developed a peptide inhibitor-based cantilever sensor assay 
for cyclic adenosine monophosphate-dependent protein kinase [59]. They immobilized 
the kinase on the bottom surface of the cantilever made up of gold. The addition of 
phosphate group on the immobilized protein resonated the piezoelectric crystal embedded 
on the top of the cantilever. Figure 7 shows the scheme of the Yang et al’s system.   
 
Figure 7 Nanomechanical detection of PKA catalytic subunit on a functionalised 
cantilever. (A) Schematic representation of the binding of on the Au surface of the PZT 
cantilever functionalised (B) Results of kinase assay test on cantilever [59]. Produced 
with permission from publisher. 
They exploited the high throughput capabilities of standard MEMS foundry process and 
produced a device with an array of 12 cantilevers.  While MEMS has the ability to 
produce high throughput drug screening devices, the standard foundry process that 
enables these processes are immature for biosensing application. For instance, it is 
challenging to independently expose electrodes in an array to a flow of fluid. The choice 
of material is also limited to silicon and gold in most processes (for eg. TSMC-
BioMEMS, UMC-MEMS) so it is not trivial to interface nanomaterials to enhance 
sensitivity of the sensor.  Interfacing MEMS with standard complementary metal oxide 
semiconductor (CMOS) technology and nanostructures presents an exploratory task for 
researchers to enable development of ultimate drug screening devices.   
Atomic Force Microscopy  
Since the protein monolayers on a surface get distorted upon phosphorylation so any 
roughness seen under atomic force microscopic (AFM) would determine the 
phosphorylation. Snir et al [54]  reported a change of 9.6 Å in the roughness of the 
sensor after phosphorylation of peptides. AFM uses a probe on the cantilever structure. 
Mechanical deflection of the cantilever is the measure of the roughness of the surface. 
Advantage of using AFM is that it is relatively simple to use. However it is too 
presumptuous to confirm reaction by just measuring the change in the roughness of sensor 
as the technique does not provide information on the unwanted or non-specific 
interactions of the biomolecules on the surface. Therefore it has limited scope in drug 
discovery applications. Although it may be used as an extra validation tool observe 
changes on the sensor surface upon phosphorylation.  
Infrared Spectroscopy 
Infrared spectroscopy is based on the principle that molecules absorb energies at certain 
frequencies that are characteristic of their structure.  Attenuated total reflection Fourier 
transform infrared spectroscopy (ATR–FTIR) was employed by Goldsztein et al. to study 
phosphorylation of proteins [60]. They found major changes between the wavenumber 
1300–1000 cm-1, a region where phosphate vibration occurs. Strongest peak was observed 
at 1077 cm-1. While an authentic conformation of presence of phosphate can be achieved 
using FTIR [61], it is difficult to associate the changes with phosphorylation. This is 
attributed to the fact that any non-specific attachment of the ATP will show presence of 
phosphate peaks in the sample and asserting these peaks to phosphorylated protein would 
be misleading.   In addition this technique also requires expensive instrumentation. All 
these loopholes limit its use for drug screening applications. 
Quantum dots 
 Quantum dots (QDs) are semiconductor based nanoparticles with fluorescence 
properties. These nanoparticles typical consists of 10 to 100 atoms.  A simple assay to 
detect phosphorylation of proteins was demonstrated by Shiosaki et al. using QDs [62]. 
They demonstrated that QDs interact with the negative charge on peptides upon 
phosphorylation. The interaction was quantified using fluorescence resonance energy 
transfer (FRET). FRET is a technique in which there is distance dependent energy transfer 
between two fluorophores. As shown in figure 8 the peptides were tagged with 
fluorophores and the negative charge of the phosphorylated peptides increased the 
distance between the QDs and fluorophore that caused a change in the resonance 
properties of the system. The authors studied the activity of PKC kinases in the presence 
and absence of a known inhibitor of PKC. There are few other reports in literature that 
have explored the properties of QDs to study phosphorylation of proteins  [63], [64].  
Although FRET provides remarkable sensitivity to detect the phosphorylated proteins and 
subsequently screen inhibitors of kinase, they are subjected to fluorescence quenching 
effects. This may occasionally lead to a false signal of detection.    
 Figure 8  Scheme for using quantum dots for the detection of kinase activity [62]; produced with 
permission  
Photonic crystal 
A photonic crystal biosensor was developed by MacConagy et al. to obtain dose and time 
dependent response of phosphorylation of peptides [65] [66].  The device consisted of 
crystalline colloidal array (CCA) polymerized into a hydrogel matrix. Diffraction 
measurements from the hydrogel matrix revealed that upon phosphorylation of peptides 
there is a redshift in the diffraction wavelength of the gel.  This is due to the fact that the 
negative charge of the phosphorylated protein encourages repulsion of crystals in CCA. 
This was revealed by observation of expansion in the gel upon phosphorylation. Figure 8 
shows the expansion of the hydrogen upon activity of kinase. 
 Figure 9 Expansion of hydrogen upon activity of kinase; Obtained from open access article [65]  
Contact angle 
Contact angle systems measure the wetting properties of the surface. Every surface has a 
characteristic surface tension that makes it either hydrophobic or hydrophilic in nature. 
Upon binding of biomolecules to a sensor surface, there are changes in the surface tension 
of the material that is measured by observing the spread of water on it. The angle that 
water makes on the sensor surface while it spreads is known as contact angle. 
Wieckowska et al studied phosphorylation of proteins using contact angle [67].  The 
negative charge of the phosphorylated proteins makes the sensor surface hydrophilic and 
a reduction of the contact from 67.5º to 36.8º was observed on the gold based surfaces 
[68]. Usually the measurement system is simple and it requires a camera, optical lens and 
a source of light to give the right contrast to the droplet. However, the contact angle does 
not provide any significant information on kinetics of the reaction. Therefore, it is an 
addition validation tool to confirm changes on the surface of the sensor. Whether the 
changes are due to the specific or non-specific interactions of the molecules is asserted 
by other detection mechanisms.    
Field effect devices 
Field effect transistor (FET) measures the changes of potential on the surface of an 
electrode. This research has explored the prospects of using field effect devices has drug 
screening tool. The potential is usually changed due to change in change upon a chemical 
reaction in which case a charge sensitive electrodes, for instance gold electrodes, are used 
for the measurement of the analyte. The potential change on the FETs may also be due to 
the change in the pH upon chemical reaction in which case pH sensitive material such as 
silicon nitride is used as an electrode. Freeman et al. first studied the degree of charging 
of the gate surface due to kinase activity [69]. They used aluminium oxide gated field 
effect transistor to follow the phosphorylation of proteins. They carried out simultaneous 
phosphorylation and dephosphorylation on their sensor and achieved a 40 mV change in 
the signal upon phosphorylation of proteins. Real time monitoring of the kinetics of the 
reaction was also followed. Another study that demonstrated 
phosphorylation/dephosphorylation of peptides using silicon nitride based FETs reported 
a change of 118 mV [54].  Detection of release of pH associated with phosphorylation 
of protein, changes in charge upon phosphorylation and demonstrated of  how kinase 
inhibitors could be screened was first demonstrated by this research [43], [45], [70].   
Major advantage of using FET based devices is its high throughput capabilities. Potential 
of very large scale integration technology (VLSI) to form an array of FETs to monitor 
biocatalytic transformation was explored by Ion Torrent on their DNA sequencing 
chip[71]. Whole genome sequencing was performed on that chip whereby the protons 
were produced by adding a nucleotide to each of the several molecules in a clonal colony 
of DNA [72]. This release of protons was measured by an array of FETs. Similarly if 
entire human proteome is printed on an array of ISFETs such that there is one type of 
protein above each FET, then it will be possible to address the whole human proteome 
and study which protein was phosphorylated with a given kinase [73]. This would also 
make it possible to know how various inhibitors (drugs) of kinase affect that particular 
protein phosphorylation [73,74]. Therefore, its application in development of 
miniaturized rapid drug discovery platform is of prime significance.  
Plasmonic biosensors 
The quantum associated with collective oscillations of electrons that takes place when 
light is shinned on a material with specific dielectric constant is known as plasmon. 
Materials that satisfy the large negative real dielectric constant and small imaginary 
dielectric constant refractive index show the presence of plasmons and are generally 
called plasmonic material [75]. The concept of plasmonic biosensor is based on the 
interaction of surface plasmon wave produced at the interface of the plasmonic material 
and an isotropic media for light. Plasmonic biosensors can be categorised into surface 
plasmon resonance (SPR) and localized surface plasmon resonance (LSPR) based 
detection systems.   
Thin planar films of gold (< 100 nm) are one of the materials that satisfies the 
requirements of plasmons. To excite surface plasmons on the gold the most common 
configuration is the Kretschmann configuration where the light is shinned through a prism 
at  ‘just near’ to the critical angle of incidence. At angles near to critical angle of 
incidence, there is total internal reflection of the light and it is allowed to pass through 
the other media (gold film). The variations in the light that passes through the other media 
can be measured as a change in the angle of the total internal reflected light.  These 
variations are usually brought in by the interactions of plasmonic evanescent wave with 
the biomolecules attach on the surface. On the other hand LSPR works with the similar 
physics except that the formation of plasmons is on nanoscale materials.  
Nordin et al. is the only exclusive report that demonstrated the use of  SPR biosensors 
to screen inhibitors of kinase [76. The work successfully demonstrated the use of SPR to 
study direct binding of inhibitors to the kinases and a detailed kinetic analyses of their 
binding events. On the other hand use of LSPR to screen inhibitors of the kinase was first 
demonstrated by the work reported in the thesis. The LSPR was combined with the field 
effect devices as complementary biosensors to confirm phosphorylation of proteins [43]. 
Detailed description of the technique is demonstrated in the following chapters.   
 2.16 Conclusions 
This review reported a survey of techniques used by the researchers to study 
phosphorylation of proteins for the development of kinase inhibitor screening devices. 
While highly sophisticated assays and devices have been reported in literature to study 
kinase activity, the research is still pre-mature to develop a high throughput drug 
screening device.  Therefore, there is a lot of scope to develop simple biosensors to study 
phosphorylation of proteins. To overcome this there is a need for the researchers from 
chemistry/biology and other basic sciences to closely work with the researchers in the 
field of nano/micro-engineering and electronics as biosensors is highly interdisciplinary 
area of research. 
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